← Research & Industry News
External source
This week in charts: a big year for RNAi developers
The latest installment in BioPharma Dive's data visualization series features a look at the emerging popularity of RNAi developers, and the funding that came with it.
- Published by
- BioPharma Dive
- Evidence type
- Industry
The latest installment in BioPharma Dive's data visualization series features a look at the emerging popularity of RNAi developers, and the funding that came with it.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at BioPharma Dive.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.